Clinical Trials Logo

Shock, Septic clinical trials

View clinical trials related to Shock, Septic.

Filter by:

NCT ID: NCT05080543 Not yet recruiting - Septic Shock Clinical Trials

Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients

Start date: October 2021
Phase: Phase 1
Study type: Interventional

The aim of this study is to evaluate the effect of combining HSA 20% and terlipressin on the microcirculation in patients with septic shock using the following;- - Microcirculation recruitment by Cytocam-IDF. - Cardiac output by LiDCOrapid. - Measuring serum lactate level.

NCT ID: NCT04913181 Not yet recruiting - Septic Shock Clinical Trials

Artificial Intelligence for Sepsis Prediction in ICU

AICUSepsis
Start date: June 1, 2021
Phase:
Study type: Observational

The development of sepsis prediction model in line with Chinese population, and extended to clinical, assist clinicians for early identification, early intervention, has a good application prospect. This study is a prospective observational study, mainly to evaluate the accuracy of the previously established sepsis prediction model. The occurrence of sepsis was determined by doctors' daily clinical judgment, and the results of the sepsis prediction model were matched and corrected to improve the clinical accuracy and applicability of the sepsis prediction model.

NCT ID: NCT04693923 Not yet recruiting - Septic Shock Clinical Trials

Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients

AUSTRALIS
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

In septic shock patients, the hemodynamic coherence between systemic, regional and microcirculatory blood flow can be tracked by "capillary refill time (CRT) response to an increase in stroke volume induced by a rapid fluid challenge". A parallel improvement in regional blood flow, microcirculation and hypoperfusion-related parameters should be expected in CRT-responders as reflection of preserved hemodynamic coherence. CRT non-response is associated with a more severe systemic inflammatory state, endothelial and microvascular dysfunction, and a higher adrenergic tone. The objective of this study is to determine if CRT response after a rapid fluid challenge signals a state of hemodynamic coherence as demonstrated by a parallel improvement in regional and microcirculatory blood flow in CRT-responders, and to explore the pathophysiological mechanisms associated to CRT non-response.

NCT ID: NCT04690530 Not yet recruiting - Septic Shock Clinical Trials

Cerebral Hemodynamics and Oxygenation in Critically Ill Patients

Start date: March 1, 2022
Phase:
Study type: Observational

Critically-ill patients frequently experience marked changes in mean arterial pressure and carbon dioxide partial arterial pressure, the two major determinants of the cerebral blood flow. In addition, many therapeutics (fluids, vasopressors or inotropes administration, blood transfusion, prone positioning...) can influence these two determinants of cerebral blood flow and thus cerebral blood flow, especially in patients with altered cerebral autoregulation. Nevertheless, cerebral hemodynamics and oxygenation, as well as the effects of the different therapeutics on it have been poorly studied in critically-ill patients. In addition, it has been suggested that impaired cerebral blood flow and impaired cerebral microcirculation may be involved in the pathophysiology of septic encephalopathy in patients with sepsis and/or septic shock. In this study, we aimed to characterize and investigate the effects of different therapeutics on cerebral hemodynamics and oxygenation in critically-ill patients.

NCT ID: NCT04507672 Not yet recruiting - Clinical trials for Septic Shock Hyperdynamic

Acetated Ringer's Solution Versus Saline in Patients With Septic Shock

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.

NCT ID: NCT04449757 Not yet recruiting - Septic Shock Clinical Trials

Bicarbonated Ringer's Solution Versus Lactated Ringer's Solution in Patients With Septic Shock

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

In this prospective randomized controlled trial, investigators aim to study the effects and safety of bicarbonated Ringer's solution in patients with septic shock compared with lactated ringer's solution, and provide evidence for current fluid resuscitation strategies for septic shock.

NCT ID: NCT04365010 Not yet recruiting - Septic Shock Clinical Trials

Low-chlorine Vs High-chlorine Crystalloids in Septic Shock Adults

Start date: May 2020
Phase: Phase 4
Study type: Interventional

Fluid resuscitation is an important treatment in septic shock patients, however whether crystalloid composition affects septic shock patients outcomes remains unclear. According to previous studies, low-chlorine crystalloids could significantly reduce the incidence of kidney injury and 30-day mortality compared with high-chlorine crystalloids in critically ill adults. Therefore, we hypothesized that the use of low-chlorine crystalloids would result in a lower incidence of major adverse kidney events within 30 days (MAKE 30: overall incidence of death, new renal-replacement therapy, and persistent renal dysfunction) than high-chlorine crystalloids in septic shock adults.

NCT ID: NCT04295993 Not yet recruiting - Septic Shock Clinical Trials

Methylene Blue and Microcirculation in Septic Shock

Start date: March 10, 2020
Phase: Phase 3
Study type: Interventional

This trial aims to identify the effects of methylene blue infusion on the the micro-circulation in patients with septic shock. The investigators will evaluate various indices of micro-circulation such as: microvascular flow index, the flow heterogeneity index, the total vessel density, the perfused vessel density, and the proportion of perfused vessels.

NCT ID: NCT04282252 Not yet recruiting - Septic Shock Clinical Trials

The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation

Start date: February 24, 2020
Phase: Phase 4
Study type: Interventional

The study aims to compare the effects of restrictive fluid management on cardiac dysfunction and vascular integrity in septic shock patients. To achieve this, patients with septic shock according to Sepsis-3 criteria admitted to several Intensive Care Units in Sweden and Denmark will be randomized to receive restrictive respectively standard fluid therapy. Blood test from these patients will be analyzed for several biomarkers of cardiac function and glycocalyx degradation. Echocardiography will also be performed to further investigate cardiac function.

NCT ID: NCT04257838 Not yet recruiting - Sepsis Clinical Trials

Monitoring of Piperacillin-Tazobactam and Meropenem Plasmatic Levels in Critical Patients

Start date: February 15, 2020
Phase:
Study type: Observational

The aim of this study is to establish the Piperacillin-Tazobactam and Meropenem Plasmatic Levels to know if it´s necessary to make some adjustment in the recommended dose regimen.